Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.14.4 - dipeptidyl-peptidase III

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Breast Neoplasms
Nudt3 is an mRNA decapping enzyme that modulates cell migration.
Carcinoma
Dipeptidyl Peptidase III: A Multifaceted Oligopeptide N-end Scissor.
Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas.
Cataract
Peptidases play an important role in cataractogenesis: an immunohistochemical study on lenses derived from Shumiya cataract rats.
Proteases in the Emory mouse cataract.
Endometrial Neoplasms
Dipeptidyl peptidase III in malignant and non-malignant gynaecological tissue.
Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas.
Glioblastoma
Ets-1/Elk-1 is a critical mediator of dipeptidyl-peptidase III transcription in human glioblastoma cells.
Transcription factor C/EBP-? mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells.
Hypertension
Novel Therapeutic Role for Dipeptidyl Peptidase III in the Treatment of Hypertension.
On Endogenous Angiotensin II Antagonism in Hypertension: The Role of Dipeptidyl Peptidase III.
Leiomyoma
Dipeptidyl peptidase III in malignant and non-malignant gynaecological tissue.
Leishmaniasis
Dipeptidyl peptidase III as a DNA marker to investigate epidemiology and taxonomy of Old World Leishmania species.
Leukemia, Lymphocytic, Chronic, B-Cell
Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
Leukemia, T-Cell
Enzymecytochemical heterogeneity of human chronic T-lymphocytic leukemia as demonstrated by reactivity to dipeptidylaminopeptidase IV (DAP IV; EC 3.4.14.4).
Neoplasms
Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study.
Dipeptidyl peptidase III in malignant and non-malignant gynaecological tissue.
Human dipeptidyl peptidase III mRNA variant I and II are expressed concurrently in multiple tumor derived cell lines and translated at comparable efficiency in vitro.
Peptidases released by necrotic cells control CD8+ T cell cross-priming.
The first structure of dipeptidyl-peptidase III provides insight into the catalytic mechanism and mode of substrate binding.
Transcription factor C/EBP-? mediates downregulation of dipeptidyl-peptidase III expression by interleukin-6 in human glioblastoma cells.
Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas.
Neuromuscular Diseases
Dipeptidyl peptidases in human muscle disease.
Obesity
DNA methylation signature in blood mirrors successful weight-loss during lifestyle interventions: the CENTRAL trial.
The Obesity-Linked Gene Nudt3 Drosophila Homolog Aps Is Associated With Insulin Signaling.
What model organisms and interactomics can reveal about the genetics of human obesity.
Ovarian Neoplasms
Total tissue lactate dehydrogenase activity in endometrial carcinoma.
Sarcopenia
Disentangling the genetics of sarcopenia: prioritization of NUDT3 and KLF5 as genes for lean mass & HLA-DQB1-AS1 for hand grip strength with the associated enhancing SNPs & a scoring system.
Wilms Tumor
Canonical and non-canonical mechanisms of Nrf2 activation.